Summit
FT Global Pharmaceutical and Biotechnology Summit
A senior executive conference addressing commercial, regulatory, and technological forces shaping the global pharmaceutical and biotechnology industries.
- When
- November, Early November
- Where
- London, UKView on Google Maps
- Format
- Hybrid
- Organiser
- Financial Times
- Region
- Europe
- Scale
- About 500 attendees
- Founded
- 2011
The Signal
The FT Global Pharmaceutical and Biotechnology Summit is an annual executive level event organized by the Financial Times in London. It convenes global pharma CEOs, biotech leaders, policymakers, and investors to debate the geopolitical, financial, and digital forces transforming healthcare. The summit covers drug pricing, clinical innovation, and the integration of artificial intelligence in drug discovery. For healthtech operators, it provides strategic insight into how large pharmaceutical firms buy and deploy digital solutions.
What to expect
- Debates on global drug pricing policies and regulatory reforms
- Discussions on generative artificial intelligence in therapeutic drug discovery
- Insights into pharmaceutical mergers, acquisitions, and strategic partnerships
Who is in the room
Pharmaceutical executives, biotechnology founders, life science investors, healthcare policymakers, and technology providers.
Background
Established by the Financial Times, the summit leverages the publication's editorial network to secure top tier industry speakers. It has evolved from a traditional pharmaceutical business conference to a forum heavily focused on biotechnology, digital medicine, and global health security. It is highly regarded for its editorial independence and critical debates.
Related events
Running this event, or spotted something out of date?